Improving Access and Affordability of Adult Hearing Healthcare
Launched by UNIVERSITY OF ALABAMA, TUSCALOOSA · Dec 10, 2020
Trial Information
Current as of June 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on improving access and affordability for adults who have mild-to-moderate hearing loss, particularly those who may not have had proper access to hearing healthcare. The study will explore three different approaches using over-the-counter hearing aids to help more people benefit from hearing support. By participating in this trial, adults in West Central or South Alabama can help researchers find better ways to provide hearing care to those who need it.
To be eligible for this trial, participants must be at least 40 years old, have mild-to-moderate hearing loss, and live in the specified regions. It’s important to note that individuals with severe cognitive impairments, such as those caused by a stroke or Alzheimer's disease, will not be included. Participants can expect to try out various hearing aid options and share their experiences, which will contribute to improving hearing healthcare for others. If you or a loved one meet the criteria and are interested, this could be a great opportunity to help advance hearing care solutions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Mild-to-moderate hearing loss
- • Live in West Central or South Alabama
- • 40 years of age or older
- Exclusion Criteria:
- • • Medical conditions resulting in severe cognitive impairment (e.g., stroke, head injury, senile dementia or Alzheimer's disease)
About University Of Alabama, Tuscaloosa
The University of Alabama, Tuscaloosa, is a leading academic institution dedicated to advancing research and innovation in various fields, including medicine and healthcare. As a clinical trial sponsor, the university leverages its extensive resources, expert faculty, and state-of-the-art facilities to conduct rigorous research that aims to enhance patient care and contribute to medical knowledge. The university fosters collaboration among interdisciplinary teams, ensuring a comprehensive approach to clinical research that prioritizes participant safety and ethical standards. Through its commitment to excellence, the University of Alabama, Tuscaloosa, plays a pivotal role in translating scientific discoveries into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Tuscaloosa, Alabama, United States
Patients applied
Trial Officials
Marcia J Hay-McCutcheon, PhD
Principal Investigator
The University of Alabama, Tuscaloosa
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials